Chronic Fatigue Clinical Trial
— FRDOfficial title:
Fatigue Reduction Diet in Breast Cancer Survivors
Verified date | February 2017 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There are over 2 million breast cancer survivors today. Persistent cancer-related fatigue
(PCRF), a state of being tired or weary, is one of the most common and distressing symptoms
experienced by breast cancer (BC) survivors. PCRF is associated with decreased quality of
life, decreased sleep quality, depression, chronic pain and impaired cognition. Currently,
there are few treatment options for PCRF and existing treatment options are associated with
significant costs, are a considerable burden on the part of the patient, or have
unacceptable side-effects. As such, there is a clear need to conduct studies evaluating the
impact of safe, easy to implement and inexpensive treatments for PCRF in BC survivors.
Individualized nutritional counseling has been found to be beneficial for decreasing fatigue
and improving quality of life in cancer patients receiving treatment.However, there is a
dearth of research examining the use of diet for treating fatigue in cancer survivors. Our
preliminary data in 40 adult cancer survivors found that fatigue severity was associated
with decreased intake of key food groups, e.g., green leafy vegetables, and nutrients, e.g.,
omega-3 fatty acids, as reported in diet records. However, diet records are often not highly
correlated with actual nutrient concentrations in the body and tend to capture short-term
dietary habits not long-term patterns. The main objective of this research is to expand upon
and confirm our cross-sectional preliminary data and to take advantage of a pilot clinical
dietary study we are conducting by examining key nutrient differences in biological samples
in the breast cancer survivors. By examining differences in biological samples we will be
able to explore three key questions, which will directly influence our future interventional
studies: (1) to determine if there are actual differences in concentrations of key nutrients
in body tissue and which nutrients these are; (2) to assess if a dietary intervention
focused on improving fatigue in BC survivors changes baseline levels of key nutrients; and
(3) what is the effect size and variability of change in key nutrients in body tissue both
at baseline and after a dietary intervention.
Status | Completed |
Enrollment | 30 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years of age and older - Diagnosis of breast cancer - Have completed all cancer related treatments (i.e. surgery, chemotherapy, radiotherapy, immunotherapy, etc.) at least 1 year prior to enrollment except hormone therapy which must have been initiated at least three weeks prior to enrollment - Apparently cancer-free - Have a complaint of persistent, moderate to severe fatigue despite standard treatment [defined as = 4 on the Brief Fatigue Inventory (BFI)] - Dietary eligibility requirements from a seven-day food record fruit and vegetable (FV) intake less than <5.5 servings/day, not including potatoes and iceberg lettuce. Exclusion Criteria: - Participants with BMI <18.5 or >35 kg/m2 will be excluded since low BMI could indicate eating disorders and high BMI values, above the midpoint of the obesity range, could indicate more prevalent health problems - Have a diagnosis of untreated hypo- or hyper- thyroidism - Pregnant, wanting to become pregnant or lactating women - Unable to read and/ or write in English - Planning on starting or stopping any chronic supplements or medications within six weeks prior to or throughout the study period |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | University of Michigan Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fatigue in Breast Cancer Survivors | Brief Fatigue Inventory(BFI)will be filled out to assess the changes in fatigue at screening, baseline and the final 3 month visit. The BFI assesses the severity of fatigue and the impact of fatigue on daily functioning in patients with fatigue due to cancer and cancer treatment. | 12 weeks | |
Secondary | Tolerability, Goals, Beliefs and Expectations of Participants | Tolerability, goals, beliefs and expectations of participants will be obtained through face to face conversations and over the phone. All counseling sessions will be documented into daily logs for future reference. | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02517151 -
Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
|
Phase 2 | |
Completed |
NCT01046370 -
A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia
|
N/A | |
Completed |
NCT02865460 -
Coenzyme Q10 Phase III Trial in Gulf War Illness
|
Phase 3 | |
Recruiting |
NCT05367245 -
Ca-Mg Butyrate in GWI
|
Phase 2 | |
Recruiting |
NCT01926132 -
High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study
|
Phase 4 | |
Completed |
NCT01281904 -
Acupressure for Persistent Cancer Related Fatigue
|
Phase 2/Phase 3 |